DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Tralokinumab is an investigational drug.
There have been 13 clinical trials for Tralokinumab. The most recent clinical trial was a Phase 2 trial, which was initiated on June 19th 2018.
The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are LEO Pharma, Emma.Guttman, and AstraZeneca.
There are seven US patents protecting this investigational drug and eighty-two international patents.
Recent Clinical Trials for Tralokinumab
|A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects||LEO Pharma||Phase 1|
|Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis||LEO Pharma||Phase 3|
|Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function||Prof. Dr. Stephan Weidinger||Phase 2|
Top disease conditions for Tralokinumab
Top clinical trial sponsors for Tralokinumab
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Tralokinumab||Get Started Free||Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein||CureVac AG (Tubingen, DE)||Get Started Free|
|Tralokinumab||Get Started Free||Cholestosome vesicles for incorporation of molecules into chylomicrons||THERASYN SENSORS, INC. (Eggertsville, NY)||Get Started Free|
|Tralokinumab||Get Started Free||Compositions and methods for treating fibrotic disease||eFFECTOR Therapeutics Inc. (San Diego, CA)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Tralokinumab||Australia||AU2013220749||2032-02-15||Get Started Free|
|Tralokinumab||Brazil||BR112014019627||2032-02-15||Get Started Free|
|Tralokinumab||Canada||CA2862476||2032-02-15||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|